Literature DB >> 33707395

A validation study of early warning system in high-risk pregnant women.

Asmita Muthal Rathore1, Sunita Bai Meena2, Reena Rani3, Deepti Goswami1, Reva Tripathi4.   

Abstract

High-risk obstetric patients have chances of deterioration which can be detected by any early warning score. This study was aimed to assess the suitability of the Obstetrics National Early Warning System (ONEWS) for the pregnant women. This prospective study was conducted on 500 high-risk pregnant women attending a tertiary care teaching hospital. The ONEWS charts were plotted for each of them. The primary outcome measure was composite adverse maternal outcome (CAMO) in the form of one or more among mortality, severe maternal morbidity and intensive care unit admissions. Of the 500 women who participated, 200 (40%) had a score ≥3 (triggered an intervention). The CAMO among the triggered group [59.5% (n=119)] was significantly higher compared to that in the non-triggered group [13.3% (n=40) (P=0.001)]. The area under the receiver operating characteristic curve was 0.800 (95% confidence interval 0.752-0.847). The sensitivity of the ONEWS in predicting CAMO was 74.8 per cent, specificity 76.2 per cent, positive predictive value 59.5 per cent and negative predictive value 86.7 per cent at a cut-off score of 3. ONEWS appears to be a useful tool for predicting adverse maternal outcomes in high-risk pregnant women.

Entities:  

Keywords:  Adverse maternal outcomes; early warning score; high-risk pregnancy; physiological parameters; severe maternal morbidity

Mesh:

Year:  2020        PMID: 33707395      PMCID: PMC8157899          DOI: 10.4103/ijmr.IJMR_1649_18

Source DB:  PubMed          Journal:  Indian J Med Res        ISSN: 0971-5916            Impact factor:   2.375


Patients at a risk of rapid deterioration and critical illness often have preceding changes in their physiological parameters. Identifying such patients at an early stage using a simple protocol, based on physiological parameters may avoid maternal mortality. An early warning system (EWS) uses physiological parameters to track a patient's condition, detect deterioration early and trigger an increased level of care1. An EWS has three components: (i) Early warning score - a tool to aid the recognition and management of a pregnant women whose condition is deteriorating; (ii) Tracking - periodic observation and recording of physiological parameters on an observation chart; and (iii) Trigger - predetermined cut-off score will trigger the summoning of help, involving a timely response and an appropriate level of assistance1. A variety of EWSs have been developed in non-obstetric adult populations, but none of these are validated for the obstetric population. Normal physiological changes during pregnancy may alter the significance of physiological parameters, and thus, application of these scores in pregnancy may need modification. The Confidential Enquiry into Maternal and Child Health UK Report 2003-2005 recommended the routine use of the modified early obstetric warning system2. There is a paucity of literature regarding the use of EWS in pregnant Indian women. Although many EWSs3456 have been described, the Obstetric National Early Warning System (ONEWS)7 used in Wales, UK, based on 10 physiological parameters for bedside evaluation in pregnant women was found suitable in the Indian context. The objective of this study was to validate and assess the suitability of ONEWS7 in high-risk pregnant Indian women. This was a prospective observational study conducted at the department of Obstetrics and Gynecology, Maulana Azad Medical College and associated Lok Nayak Hospital, New Delhi, India, from October 2013 to April 2015. By assuming the prevalence of composite adverse maternal outcome (CAMO) as about 20 per cent, the minimum risk for CAMO was expected to be 2.5 times higher for a particular predictor (odds ratio 2.5)8. Further, assuming alpha and beta error as 5 and 10 per cent, respectively, to account for many confounders, multiple correlation coefficient was assumed to be 0.489. With these values, a sample size of about 500 (exactly 482) was required to get the predictors for CAMO. The inclusion criteria were any pregnant women during pregnancy or within 42 days of delivery or termination of pregnancy who had any one or more of the following: high-risk pregnant woman admitted from obstetrics and gynaecology emergency, had undergone surgery within the last 24 h, and was already admitted in obstetrics ward and became sick. The women admitted directly to the intensive care unit (ICU) were excluded. The study protocol was approved by the Institutional Ethics Committee, and informed written consent was obtained from all participants. After a complete clinical evaluation, ONEWS7 was administered at the time of admission to the hospital. The frequency of tracking was decided by the total score on admission. Women with a total score of 0-2 were monitored 12 hourly, a score of 3-5 every 2-4 hourly, a score of 6-8 every 1-2 hourly and with a score of ≥9 were continuously monitored with multiparameter monitor. These women were followed up until discharge from the hospital. The outcome measured was CAMO which included occurrence of one or more among severe maternal morbidity, ICU admission and maternal death. Severe maternal morbidity included those women with organ dysfunction who survived10. The mean age was 26.03±3.82 yr; 61.8 per cent (n=309) were multiparous, 58 per cent (n=290) were literate and 86 per cent (n=430) belonged to a low socio-economic status. The incidence of severe maternal morbidity was 49.7 per cent in illiterate women. Of the 488 antenatal women, 336 delivered during the study period. Among the 500 women, 325 were booked while 175 were unbooked. CAMO was found in 61 (34.85%) unbooked and in 98 (30.15%) booked women. CAMO was observed in 159 of 500 (31.8%) women. Of these, the incidence of CAMO was 22 of 158 (13.9%) women who had score of zero, 17 of 142 (11.9%) women who had score of 1-2, 44 of 111 (39.6%) women who had score of 3-4, 66 of 74 (89%) women who had score of 6-8 and 10 of 15 (66%) women who had with score of ≥9. The area under receiver operating characteristic (AUROC) curve is shown in the Figure. The sensitivity of the ONEWS in predicting CAMO was 74.8 per cent, specificity 76.2 per cent, positive predictive value 59.5 per cent and negative predictive value 86.7 per cent at a cut-off score of 3. The AUROC for ONEWS in our study (0.80, 0.95% CI 0.752-0.847) was lower as compared to the results of other studies456, which ranged from 0.937 to 0.995. Out of 159 women in which CAMO was observed, major obstetric haemorrhage was observed in 29 (18%), pre-eclampsia/eclampsia in 96 (62.7%), renal dysfunction in 13 (8.49%), liver dysfunction in 14 (9.1%), cardiac arrest in seven (4.5%), pulmonary oedema in six (3.9%), acute respiratory dysfunction in five (3.2%), cerebrovascular event in one (0.65%), septicaemic shock in two (1.3%) and massive pulmonary embolism in three (1.9%) women.
Figure

ROC curve and corresponding AUC. ROC curves typically feature true-positive rate (sensitivity) on the Y-axis and false-positive rate (1-specificity) on the X-axis for different cut-off points of a parameter. The area under ROC curve was 0.800 (95% CI 0.752-0.847). The sensitivity of the ONEWS in predicting adverse maternal outcome was 74.8 per cent, specificity 76.2 per cent, positive predictive value 59.5 per cent and negative predictive value 86.7 per cent using a cut-off score of 3. Diagonal segments are produced by ties. ROC, receiver operating characteristic; AUC, area under the curve; CI, confidence interval; ONEWS, Obstetrics National Early Warning System.

ROC curve and corresponding AUC. ROC curves typically feature true-positive rate (sensitivity) on the Y-axis and false-positive rate (1-specificity) on the X-axis for different cut-off points of a parameter. The area under ROC curve was 0.800 (95% CI 0.752-0.847). The sensitivity of the ONEWS in predicting adverse maternal outcome was 74.8 per cent, specificity 76.2 per cent, positive predictive value 59.5 per cent and negative predictive value 86.7 per cent using a cut-off score of 3. Diagonal segments are produced by ties. ROC, receiver operating characteristic; AUC, area under the curve; CI, confidence interval; ONEWS, Obstetrics National Early Warning System. The Table shows the distribution of patients according to trigger parameter and the relative risk of severe maternal morbidity with each parameter. The most frequent triggers were diastolic blood pressure (BP), followed by systolic BP and tachycardia, as reported earlier8. The relative risk for oxygen saturation, urine output and urinary protein was higher in our study as compared to the study by Singh et al8. The Scottish Confidential Audit10 of severe maternal morbidity revealed major obstetric haemorrhage as the most common severe maternal morbidity (5.0/1000 live birth), which was similar to (2.9/1000 live birth) our study. The most common cause of maternal death in our study was obstetric haemorrhage as compared to study conducted by Saravanakumar et al11, with the most common cause of maternal death being cardiac disease.
Table

Distribution of patients according to trigger parameters

Trigger parameterNumber of patients (%) (n=500)Severe maternal morbidity (%)PRelative risk of severe adverse morbidity (95% CI)
Systolic BP >140 mmHg220 (44)90 (40.9)<0.0013.32 (2.2-5.0)
Diastolic BP >90 mmHg235 (47)98 (41.7)<0.0013.38 (2.2-5.0)
Pulse >100/min67 (13.4)28 (41.7)<0.051.76 (1.0-2.9)
Respiratory rate >20/min16 (3.2)9 (56.2)<0.053.02 (1.1-8.2)
Temperature >37.5°C12 (2.4)9 (75)<0.055.34 (1.6-17.6)
SpO2 <95%9 (1.8)8 (88.8)<0.0516.5 (2.0-135.6)
Looks/feels unwell32 (6.4)9 (28.1)<0.056.6 (2.9-14.6)
Neurological status AVPU7 (1.4)7 (100)<0.053.3 (2.9-3.8)
Urine output <1 ml/kg/h6 (1)5 (83.3)<0.0511.6 (1.34-100.3)
Urinary protein-yes96 (19.2)96 (100)<0.0519.3 (11.2-33.3)

CI, confidence interval; BP, blood pressure; AVPU (A-alert, V-responding to verbal commands, P-responding to painful stimulus, U-unresponsive)

Distribution of patients according to trigger parameters CI, confidence interval; BP, blood pressure; AVPU (A-alert, V-responding to verbal commands, P-responding to painful stimulus, U-unresponsive) There were a total of 23 maternal deaths. The causes were obstetric haemorrhage in eight women, sepsis in six, anaemia and hypertensive disease of pregnancy in one each and others (embolism and anaesthetic problems) in seven (30.4%). All women who died had a score of ≥3. The ICU admissions in the triggered group (n=200) was 10 per cent (n=20) and in the non-triggered group (n=300) was 4.3 per cent (n=13), with the difference being significant (P<0.01). Of the total 33 (6.6%) women who were transferred to ICU, 17 (51.5%) died. The mean length of hospital stay was 8.7±6.5 days. The major limitation of our study was that this was a single-centre study and might suffer from population bias. In a resource-limited country like India, it is difficult to monitor every high-risk patient in the ICU. Development of a system which can be applied with simple bedside techniques without need of high cost and maintenance equipment and can be performed by junior doctors or nurses is relevant. It would facilitate early identification of sick women and is expected to result in the reduction in maternal mortality and morbidity12. To conclude, ONEWS may be used for predicting CAMO in high-risk pregnant women. Further research may be directed to increase sensitivity and specificity by lowering the threshold at which morbidity is defined.
  9 in total

1.  Multiple correlation coefficient.

Authors:  M Nijsse
Journal:  Biometrics       Date:  1991-03       Impact factor: 2.571

2.  A validation study of the CEMACH recommended modified early obstetric warning system (MEOWS).

Authors:  S Singh; A McGlennan; A England; R Simons
Journal:  Anaesthesia       Date:  2011-11-09       Impact factor: 6.955

3.  High dependency care in an obstetric setting in the UK.

Authors:  K Saravanakumar; L Davies; M Lewis; G M Cooper
Journal:  Anaesthesia       Date:  2008-10       Impact factor: 6.955

4.  Design and internal validation of an obstetric early warning score: secondary analysis of the Intensive Care National Audit and Research Centre Case Mix Programme database.

Authors:  C Carle; P Alexander; M Columb; J Johal
Journal:  Anaesthesia       Date:  2013-04       Impact factor: 6.955

5.  The patient-at-risk team: identifying and managing seriously ill ward patients.

Authors:  D R Goldhill; L Worthington; A Mulcahy; M Tarling; A Sumner
Journal:  Anaesthesia       Date:  1999-09       Impact factor: 6.955

6.  A physiologically-based early warning score for ward patients: the association between score and outcome.

Authors:  D R Goldhill; A F McNarry; G Mandersloot; A McGinley
Journal:  Anaesthesia       Date:  2005-06       Impact factor: 6.955

7.  Reproducibility of physiological track-and-trigger warning systems for identifying at-risk patients on the ward.

Authors:  Christian P Subbe; Haiyan Gao; David A Harrison
Journal:  Intensive Care Med       Date:  2007-01-18       Impact factor: 17.440

8.  Quantifying severe maternal morbidity: a Scottish population study.

Authors:  Victoria Brace; Gillian Penney; Marion Hall
Journal:  BJOG       Date:  2004-05       Impact factor: 6.531

9.  A national survey of obstetric early warning systems in the United Kingdom.

Authors:  R D J Swanton; S Al-Rawi; M Y K Wee
Journal:  Int J Obstet Anesth       Date:  2009-05-19       Impact factor: 2.603

  9 in total
  2 in total

1.  Survey of Nursing Staff's Training on Early Warning Ability for Inpatients with "Three Infarcts and One Hemorrhage".

Authors:  Zhoumin Shen; Chanjuan Tang; Yanjun Hu; Yimin Cai; Huali Chen; Hongjiao Chen; Yuyu Liu; Nian Xie
Journal:  Evid Based Complement Alternat Med       Date:  2021-08-16       Impact factor: 2.629

2.  Discuss the Application of Data Services in Data Health Management of High-Risk Pregnant and Lying-In Women in Smart Medical Care.

Authors:  Leifen Shen; Weiqin Shi; Liwen Cai; Jing An; Qian Ling
Journal:  Scanning       Date:  2022-08-25       Impact factor: 1.750

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.